Department of Biochemistry, University of Zürich, Zurich, Switzerland.
Novo Nordisk A/S, Måløv, Denmark.
Nat Protoc. 2022 Mar;17(3):698-726. doi: 10.1038/s41596-021-00660-9. Epub 2022 Feb 9.
Structural studies of G-protein-coupled receptors (GPCRs) are often limited by difficulties in obtaining well-diffracting crystals suitable for high-resolution structure determination. During the past decade, crystallization in lipidic cubic phase (LCP) has become the most successful and widely used technique for obtaining such crystals. Despite often intense efforts, many GPCRs remain refractory to crystallization, even if receptors can be purified in sufficient amounts. To address this issue, we have developed a highly efficient screening and stabilization strategy for GPCRs, based on a fluorescence thermal stability assay readout, which seems to correlate particularly well with those GPCR constructs that remain native during incorporation into the LCP. Detailed protocols are provided for rapid and cost-efficient mutant and construct generation using sequence- and ligation-independent cloning, high-throughput magnetic bead-based protein purification from small-scale expressions in mammalian cells, the screening and optimal combination of mutations for increased receptor thermostability and the rapid identification of suitable chimeric fusion protein constructs for successful crystallization in LCP. We exemplify the method on three receptors from two different classes: the neurokinin 1 receptor, the oxytocin receptor and the parathyroid hormone 1 receptor.
G 蛋白偶联受体(GPCR)的结构研究常常受到获得适合高分辨率结构测定的良好衍射晶体的困难的限制。在过去的十年中,在类脂立方相(LCP)中结晶已成为获得此类晶体的最成功和广泛使用的技术。尽管经过了大量的努力,但许多 GPCR 仍然难以结晶,即使可以以足够的量纯化受体。为了解决这个问题,我们基于荧光热稳定性测定的读出,开发了一种针对 GPCR 的高效筛选和稳定化策略,该策略似乎与那些在整合到 LCP 时仍保持天然状态的 GPCR 构建体特别相关。我们提供了详细的方案,用于使用序列和连接独立克隆快速且经济高效地生成突变体和构建体,从哺乳动物细胞中小规模表达中进行高通量磁珠基蛋白纯化,筛选和优化突变体以提高受体热稳定性的最佳组合,以及快速鉴定适合 LCP 结晶的合适嵌合融合蛋白构建体。我们以三个来自两个不同类别的受体为例说明了该方法:神经激肽 1 受体、催产素受体和甲状旁腺激素 1 受体。